Zobrazeno 1 - 10
of 190
pro vyhledávání: '"Anna Maria Hoffmann"'
Autor:
Panagiotis Panagopoulos, Andreas Goules, Anna Maria Hoffmann-Vold, Eric L. Matteson, Athanasios Tzioufas
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 13 (2021)
Interstitial lung disease (ILD) is a relatively frequent manifestation of systemic autoimmune rheumatic disorders (SARDs), including systemic sclerosis (SSc), rheumatoid arthritis (RA), idiopathic inflammatory myopathies (IIM), systemic lupus erythem
Externí odkaz:
https://doaj.org/article/0588a5784c3b4901ae9facd3102d63aa
Autor:
Yukai Wang, Shaoqi Chen, Shaoyu Zheng, Zexuan Zhou, Weijin Zhang, Guangzhou Du, Angelina Mikish, Barbara Ruaro, Cosimo Bruni, Anna-Maria Hoffmann-Vold, Luna Gargani, Marco Matucci-Cerinic, Daniel E Furst
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-11 (2024)
Abstract Systemic autoimmune rheumatic diseases (SARDs) related pulmonary disease is highly prevalent, with variable clinical presentation and behavior, and thus is associated with poor outcomes and negatively impacts quality of life. Chest high reso
Externí odkaz:
https://doaj.org/article/df30442c4ebe4e88999340266017ada4
Autor:
Jeffrey A. Sparks, Philippe Dieudé, Anna-Maria Hoffmann-Vold, Gerd R Burmester, Simon LF Walsh, Michael Kreuter, Christian Stock, Steven Sambevski, Margarida Alves, Paul Emery
Publikováno v:
BMC Rheumatology, Vol 8, Iss 1, Pp 1-9 (2024)
Abstract Background Patients with rheumatoid arthritis (RA) are at risk of developing interstitial lung disease (ILD), which is associated with high mortality. Screening tools based on risk factors are needed to decide which patients with RA should b
Externí odkaz:
https://doaj.org/article/7f168e26c2354e6d9a2a6c55793ae5b1
Autor:
Vanessa Smith, Oliver Distler, Anna-Maria Hoffmann-Vold, Jerome Avouac, Masataka Kuwana, Gerrit Toenges, Margarida Alves
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Objective To develop a multivariable model for predicting the progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD) over 52 weeks.Methods We used logistic regression models to analyse associations between candidate predicto
Externí odkaz:
https://doaj.org/article/320c97c2c5fd4ca28772adb36166fba7
Autor:
Jens Vikse, Øyvind Midtvedt, Bjørg-Tilde Svanes Fevang, Torhild Garen, Øyvind Palm, Marianne Wallenius, Gunnstein Bakland, Katrine Brække Norheim, Øyvind Molberg, Anna-Maria Hoffmann-Vold
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-11 (2023)
Abstract Background We investigated sensitivity of the 2020 Revised Comprehensive Diagnostic Criteria (RCD) and the 2019 ACR/EULAR classification criteria across the four identified IgG4-related disease (IgG4-RD) phenotypes: “Pancreato-Hepato-Bilia
Externí odkaz:
https://doaj.org/article/cf531b404f6b407ba40bb48035388554
Autor:
Oliver Distler, Cosimo Bruni, Anna-Maria Hoffmann-Vold, Suzana Jordan, Carina Mihai, Muriel Elhai, Marouane Boubaya, Rucsandra Dobrota, Øyvind Midtvedt, Mike Becker, Alexandru Garaiman, Håvard Fretheim, Imon Barua, Moritz Scheidegger, Hilde Jenssen Bjørkekjær
Publikováno v:
RMD Open, Vol 10, Iss 1 (2024)
Background Interstitial lung disease (ILD) is the leading cause of death in systemic sclerosis (SSc). According to expert statements, not all SSc-ILD patients require pharmacological therapy.Objectives To describe disease characteristics and disease
Externí odkaz:
https://doaj.org/article/475ee06828c44af2aa3d17552fc41486
Autor:
Kevin Windirsch, Suzana Jordan, Mike Oliver Becker, Cosimo Bruni, Rucsandra Dobrota, Muriel Elhai, Ion-Alexandru Garaiman, Carmen-Marina Mihai, Michele Iudici, Paul Hasler, Camillo Ribi, Britta Maurer, Armando Gabrielli, Anna-Maria Hoffmann-Vold, Oliver Distler
Publikováno v:
Swiss Medical Weekly, Vol 154, Iss 2 (2024)
OBJECTIVES: Systemic sclerosis is a chronic autoimmune connective tissue disease leading to microvascular and fibrotic manifestations in multiple organs. Several treatment options and recommendations from different European countries are available. I
Externí odkaz:
https://doaj.org/article/5d6f33efdb7f4ccebccb86adf0418804
Autor:
Toby M Maher, Michael Kreuter, Vincent Cottin, Daniel Wachtlin, Anna-Maria Hoffmann-Vold, Marlies S Wijsenbeek, Fernando J Martinez, Shervin Assassi, Luca Richeldi, Arata Azuma, Justin M Oldham, Claudia Valenzuela, Carl Coeck, Christina Schlecker, Florian Voss
Publikováno v:
BMJ Open Respiratory Research, Vol 10, Iss 1 (2023)
Introduction Progressive pulmonary fibrosis (PPF) includes any diagnosis of progressive fibrotic interstitial lung disease (ILD) other than idiopathic pulmonary fibrosis (IPF). However, disease progression appears comparable between PPF and IPF, sugg
Externí odkaz:
https://doaj.org/article/0431457e10d0437986592042ea5048ab
Autor:
Oliver Distler, Jeroen J Bax, Jeska De Vries-Bouwstra, Anna-Maria Hoffmann-Vold, Laura Groseanu, Nina Ajmone Marsan, Federico Fortuni, Nina Marijn van Leeuwen, Tea Gegenava, Anders H Tennoe, Ruxandra Jurcut, Adrian Giuca, Felix Tanner
Publikováno v:
RMD Open, Vol 9, Iss 4 (2023)
Background Cardiovascular involvement is one of the leading causes of mortality in systemic sclerosis (SSc) and is reported to be higher in men as compared with women. However, the cause of this difference is largely unknown. The objective of this st
Externí odkaz:
https://doaj.org/article/2224fb66ffa44d3985938301a0af5600
Autor:
Gizal Nakshbandi, Catharina C. Moor, Katerina Antoniou, Vincent Cottin, Anna-Maria Hoffmann-Vold, Edwin A. Koemans, Michael Kreuter, Philip L. Molyneaux, Wim A. Wuyts, Marlies S. Wijsenbeek
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Pulmonary fibrosis (PF) is caused by a heterogeneous group of diseases, with a high inter-individual variability in disease trajectory. Identifying disease progression in patients with PF has impact on clinical management decision
Externí odkaz:
https://doaj.org/article/208e2af0e837454b93041009cf411eb9